Conflictos de Intereses en las Evaluación de Tecnologías Sanitarias

Percy  Herrera Añazco; Agueda Muñoz-de-Carpio-Toia

doi:10.35434/rcmhnaaa.2024.173.2392

Authors

Percy Herrera Añazco Universidad Privada del Norte, Trujillo, Peru
Agueda Muñoz-de-Carpio-Toia Vicerrectorado de Investigación, Escuela de Posgrado. Universidad Católica de Santa María, Arequipa, Peru.

DOI:

https://doi.org/10.35434/rcmhnaaa.2024.173.2392

Keywords:

Technology Assessment, Biomedical, Ethics, Health Systems, Equipment and Supplies

Abstract

Health Technology Assessment (HTA) is a multidisciplinary process that systematically evaluates the properties, effects, and impact of health care technology; however, conflicts of interest may influence the selection of technologies to be evaluated or directly influence the process and decision-making. These conflicts of interest can invalidate an HTA, so it is considered important to declare them as a fundamental part of this process. However, despite its importance, not all agencies that develop HTAs worldwide include a declaration of conflicts of interest, so there is a risk of inefficient allocation of resources by providing coverage to interventions that offer little or no benefit or that prevent or delay patients' access to useful health technologies.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Percy Herrera Añazco, Universidad Privada del Norte, Trujillo, Peru

Médico

Agueda Muñoz-de-Carpio-Toia, Vicerrectorado de Investigación, Escuela de Posgrado. Universidad Católica de Santa María, Arequipa, Peru.

Médico

References

- Lessa F, Caccavo F, Curtis S, Ouimet-Rathé S, Lemgruber A. Strengthening and implementing health technology assessment and the decision-making process in the Region of the Americas. Rev Panam Salud Publica. 2017 Dec 26;41:e165. doi: 10.26633/RPSP.2017.165.

- Pichon-Riviere A, Augustovski F, García Martí S, Alfie V, Sampietro-Colom L. The link between health technology assessment and decision making for the allocation of health resources in Latin America. Int J Technol Assess Health Care. 2020 Apr;36(2):173-178. doi: 10.1017/S0266462320000033.

- Department of Health and Aged Care. Health technology assessment committees – conflicts of interest process guide [Internet]. Australia: Australian Goberment; 2020. [Citado el 22 de diciembre del 2022]. Available online: https://n9.cl/axwrc

- Clavert P, Migaud H. Why and how to declare conflicts of interest. Orthop Traumatol Surg Res. 2021 Dec;107(8):103103. doi: 10.1016/j.otsr.2021.103103.

- Trayer J, Rowbotham NJ, Boyle RJ, Smyth AR. Industry influence in healthcare harms patients: myth or maxim? Breathe (Sheff). 2022 Jun;18(2):220010. doi: 10.1183/20734735.0010-2022.

- Chimonas S, Mamoor M, Zimbalist SA, Barrow B, Bach PB, Korenstein D. Mapping conflict of interests: scoping review. BMJ. 2021 Nov 3;375:e066576. doi: 10.1136/bmj-2021-066576.

- Marcus HJ, Payne CJ, Hughes-Hallett A, Marcus AP, Yang GZ, Darzi A, Nandi D. Regulatory approval of new medical devices: cross sectional study. BMJ. 2016 May 20;353:i2587. doi: 10.1136/bmj.i2587.

- Wallach JD, Ross JS, Naci H. The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements. Clin Trials. 2018 Jun;15(3):219-229. doi: 10.1177/1740774518770648.

- Aaron DG, Siegel MB. Sponsorship of National Health Organizations by Two Major Soda Companies. Am J Prev Med. 2017 Jan;52(1):20-30. doi: 10.1016/j.amepre.2016.08.010.

- Greenhalgh S. Soda industry influence on obesity science and policy in China. J Public Health Policy. 2019 Mar;40(1):5-16. doi: 10.1057/s41271-018-00158-x.

- Rey-López JP, Gonzalez CA. Research partnerships between Coca-Cola and health organizations in Spain. Eur J Public Health. 2019 Oct 1;29(5):810-815. doi: 10.1093/eurpub/cky175.

- Diethelm PA, Rielle JC, McKee M. The whole truth and nothing but the truth? The research that Philip Morris did not want you to see. Lancet. 2005 Jul 2-8;366(9479):86-92. doi: 10.1016/S0140-6736(05)66474-4.

- Kearns CE, Schmidt LA, Glantz SA. Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents. JAMA Intern Med. 2016 Nov 1;176(11):1680-1685. doi: 10.1001/jamainternmed.2016.5394. Erratum in: JAMA Intern Med. 2016 Nov 1;176(11):1729. doi: 10.1001/jamainternmed.2016.6774.

- Testing treatments interactive [Internet]. Testing Treatments interactive. 2012 [citado el 13 de junio de 2024]. Disponible en: http://www.testingtreatments.org/

- Goodman Clifford S. Introduction to health technology assessment [Internet]. USA: The Lewin Group; 2014. [Citado el 22 de diciembre del 2022]. Available online: https://n9.cl/tmyan

- World Health Organization. 2015 Global Survey on Health Technology Assessment by National Authorities [Internet]. USA: WHO; 2015. [Citado el 22 de diciembre del 2022]. Available online: https://n9.cl/4s6or

-Pichon-Riviere A, Soto NC, Augustovski FA, García Martí S, Sampietro-Colom L. Health technology assessment for decision-making in Latin America: good practice principles. Rev Panam Salud Publica. 2018 Feb 19;41:e138. Spanish. doi: 10.26633/RPSP.2017.138.

Hofmann BM. Why ethics should be part of health technology assessment. International Journal of Technology Assessment in Health Care. Cambridge University Press; 2008;24(4):423–9.